Peter C Beverley
Overview
Explore the profile of Peter C Beverley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clutterbuck E, Lazarus R, Yu L, Bowman J, Bateman E, Diggle L, et al.
J Infect Dis
. 2012 Mar;
205(9):1408-16.
PMID: 22457293
Background: A 23-valent unconjugated pneumococcal polysaccharide vaccine (23vP), routinely administered at the age of 65, has limited effectiveness, and revaccination induces attenuated antibody responses. It is not known whether pneumococcal...
2.
Lazarus R, Clutterbuck E, Yu L, Bowman J, Bateman E, Diggle L, et al.
Clin Infect Dis
. 2011 Mar;
52(6):736-42.
PMID: 21367726
Background: The widely used 23-valent plain polysaccharide vaccine (23vP) has limited effectiveness, produces short-lived immune responses, and induces attenuated antibody production after subsequent challenge with pneumococcal vaccines. Our goal was...
3.
Wallace D, Masters J, de Lara C, Henson S, Worth A, Zhang Y, et al.
Immunology
. 2010 Aug;
132(1):27-38.
PMID: 20738423
The immune response to human cytomegalovirus (HCMV) infection is characterized by the accumulation of HCMV-specific CD8(+) T cells, particularly in the elderly; such expansions may impair immune responses to other...
4.
Pollard A, Perrett K, Beverley P
Nat Rev Immunol
. 2009 Feb;
9(3):213-20.
PMID: 19214194
Polysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and pneumonia in children. The use of protein-polysaccharide conjugate vaccines in developed countries over the past two decades has markedly decreased...
5.
Asquith B, Zhang Y, Mosley A, de Lara C, Wallace D, Worth A, et al.
Proc Natl Acad Sci U S A
. 2007 May;
104(19):8035-40.
PMID: 17483473
Human T-lymphotropic virus type 1 (HTLV-1) is a persistent CD4+ T-lymphotropic retrovirus. Most HTLV-1-infected individuals remain asymptomatic, but a proportion develop adult T cell leukemia or inflammatory disease. It is...
6.
Macallan D, Wallace D, Irvine A, Asquith B, Worth A, Ghattas H, et al.
Eur J Immunol
. 2003 Sep;
33(10):2655-65.
PMID: 14515249
During acute infectious mononucleosis (AIM), large clones of Epstein-Barr virus-specific T lymphocytes are produced. To investigate the dynamics of clonal expansion, we measured cell proliferation during AIM using deuterated glucose...
7.
Macallan D, Asquith B, Irvine A, Wallace D, Worth A, Ghattas H, et al.
Eur J Immunol
. 2003 Jul;
33(8):2316-26.
PMID: 12884307
The ability to measure, describe and interpret T cell kinetics is pivotal in understanding normal lymphocyte homeostasis and diseases that affect T cell numbers. Following in vivo labeling of dividing...